Tech Company Financing Transactions

Sensorium Therapeutics Funding Round

Sante Ventures, CU Healthcare Innovation Fund and Iter Investments participated in a $30 million Series A funding round for Sensorium Therapeutics. This venture round was announced on 11/8/2022.

Transaction Overview

Company Name
Sensorium Therapeutics
Announced On
11/8/2022
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors

Sante Ventures (Lead Investor) (Kevin Lalande)

CU Healthcare Innovation Fund

Iter Investments

Ocama Partners

Palo Santo

re.Mind Capital

Route 66 Ventures

WPSS.bio

Proceeds Purpose
The financing will support advancement of Sensorium's platform and initial program and will also help secure growth of the company's multi-disciplinary team of experts with a passion for improving mental health.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
38 Wareham St Fl 2
Boston, MA 02118
USA
Phone
Undisclosed
Website
www.sensorium.bio
Email Address
[email protected]
Overview
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium's groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world.
Profile
Sensorium Therapeutics LinkedIn Company Profile
Social Media
Sensorium Therapeutics Company Twitter Account
Company News
Sensorium Therapeutics News
Facebook
Sensorium Therapeutics on Facebook
YouTube
Sensorium Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Richard Simon
  Richard Simon LinkedIn Profile  Richard Simon Twitter Account  Richard Simon News  Richard Simon on Facebook
Co-Founder
Stephen Haggarty
  Stephen Haggarty LinkedIn Profile  Stephen Haggarty Twitter Account  Stephen Haggarty News  Stephen Haggarty on Facebook
Co-Founder
Jerrold Rosenbaum
  Jerrold Rosenbaum LinkedIn Profile  Jerrold Rosenbaum Twitter Account  Jerrold Rosenbaum News  Jerrold Rosenbaum on Facebook
Co-Founder
Alex Simon
  Alex Simon LinkedIn Profile  Alex Simon Twitter Account  Alex Simon News  Alex Simon on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/8/2022: BC Platforms venture capital transaction
Next: 11/8/2022: doola venture capital transaction

 

Share this article

 

About Our VC Transactions Data

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.